Conditioning Agent
R-CLOSTRIDIUM HISTOLYTICUM COLLAGENASE H HEXAPEPTIDE-40
Safety score · 0–100
Fine
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
A fusion of bacterial collagenase and a synthetic hexapeptide, designed to promote extracellular matrix remodelling in skin.
This recombinant fusion combines a Clostridium-derived collagenase domain with Hexapeptide-40, expressed in E. coli. Bacterial collagenases are enzymes capable of degrading collagen and are generally restricted in EU cosmetics to low concentrations to avoid tissue irritation. The peptide component is a short synthetic sequence with no known toxicity. Combined, the ingredient occupies a borderline safety profile — effective at low concentrations but requiring careful formulation controls due to enzymatic activity.
Function
Skin benefits
- May assist skin remodelling by selectively degrading damaged collagen
- Hexapeptide component may provide targeted peptide signalling
Known concerns
- Enzymatic collagenase activity may cause irritation at higher concentrations
- EU Annex III restricts enzyme-based cosmetic ingredients to prevent tissue damage
- Risk of sensitisation from bacterial protein contaminants
References
EU CosIng database
European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.
Related conditioning agents
Same plant / compound family
Check your shelf
Find R-CLOSTRIDIUM HISTOLYTICUM COLLAGENASE H HEXAPEPTIDE-40 in your products.
Scan any cosmetic product with LuxSense to see if it contains R-CLOSTRIDIUM HISTOLYTICUM COLLAGENASE H HEXAPEPTIDE-40 and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.